Mechanical Tricuspid Valve Thrombosis Successfully Treated With Tissue Plasminogen Activator
- PMID: 38361569
- PMCID: PMC10865125
- DOI: 10.1016/j.jaccas.2023.102180
Mechanical Tricuspid Valve Thrombosis Successfully Treated With Tissue Plasminogen Activator
Abstract
Prosthetic mechanical valve thrombosis has traditionally been managed with urgent surgical intervention. However, the risk of redo sternotomy can be prohibitively high in some patients. Thrombolytic therapy as a noninvasive treatment of mechanical valve thrombosis is a well-recognized alternative, but optimal dosing and patient selection remain incompletely characterized for right-side mechanical valves.
Keywords: 3D echocardiography; fluoroscopy; mechanical tricuspid valve; thrombolytics; thrombosis; tissue plasminogen activator.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Lancellotti P., Pibarot P., Chambers J., et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(6):589–590. - PubMed
-
- Dangas G.D., Weitz J.I., Giustino G., et al. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68:2670–2689. - PubMed
-
- Muratori M., Fusini L., Ghulam Ali S., et al. Detection of mechanical prosthetic valve dysfunction. Am J Cardiol. 2021;150:101–109. - PubMed
-
- Otto C.M., Nishimura R.A., Bonow R.O., et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):e25–e197. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
